In the liver, integrin α8β1 has been implicated in the progression of fibrosis in non-alcoholic fatty liver disease (NAFLD) through the activation of the RHOA signaling pathway. Here, RHOA is linked to metabolic dysfunction-associated steatotic liver disease.